← Back
Pharmacology I · Exam 3 · Class of 2028

Antiarrhythmic Drugs Compared by Class

Classes I to IV and the three miscellaneous agents side by side: what each blocks, what it does to the action potential (read off the slide pictures), what it does to conduction, what it is for, what it causes and what to avoid.

Lecture 10 — Antiarrhythmic Drugs 9 rows

Read the indications column for the trend. Class I and class III work on both supraventricular and ventricular arrhythmias; class II, class IV and the miscellaneous agents are listed for supraventricular arrhythmias (propranolol's slide adds ventricular ectopic beats, and verapamil and diltiazem are to be avoided in ventricular arrhythmias). Read the action potential column for the mechanism: class IA and IC slow phase 0 (IC the most), class IB shortens the action potential and works mainly in ischemic tissue, class III lengthens repolarization, and class II and IV flatten phase 4 in the pacemaker cells of the sinoatrial and atrioventricular nodes. Torsades de pointes belongs to the drugs that lengthen repolarization (class IA, dofetilide, sotalol) and is treated with magnesium sulfate. Doses are not tested and are left out.
Class and drugsWhat it blocksEffect on the action potentialMain actionsIndicationsMain adverse effectsAvoid, cautions and interactionsSource
Class IA
quinidine, procainamide, disopyramide
Sodium channel (prefers the open channel; slow dissociation)Slower, lower phase 0; longer action potential (slide 8 picture)Slow conduction; prolong the action potential and refractory period; quinidine is also anticholinergic and an alpha blocker at higher dosesSupraventricular tachycardia; ventricular tachycardia; prevention of ventricular fibrillation and premature ventricular contractionsTorsades de pointes; quinidine: diarrhea (30 to 50 percent), cinchonism, thrombocytopenia, quinidine sudden death; procainamide: lupus-like syndrome, bone marrow suppression; disopyramide: antimuscarinic effects, heart failureDisopyramide contraindicated in heart block and glaucoma; quinidine inhibits CYP2D6 (codeine, morphine)L10
slide 8
slide 6
slide 11
slide 13
slide 15
Class IB
lidocaine
Sodium channel (prefers the inactivated channel; rapid dissociation); higher affinity in ischemic tissue, little effect in normal tissueShorter action potential (phase 3 shortened); phase 0 unchanged (slide 16 picture)Shorten phase 3; decrease ectopic foci automaticityVentricular tachycardia and premature beats, ventricular fibrillation, acute myocardial infarction (Wolff-Parkinson-White is also listed); not effective against atrial arrhythmiasCentral nervous system toxicity: drowsiness, confusion, restlessness, muscle twitches, seizures; nystagmus is the early sign; hypersensitivityIntravenous only (extensive first-pass metabolism); contraindications: seizures, ageL10
slide 16
slide 17
slide 18
slide 19
Class IC
flecainide, propafenone
Sodium channel (prefers the open channel; very slow dissociation); flecainide also blocks potassium channels in the ventricles; propafenone also has beta-blocking activityMarkedly slower phase 0 (slide 20 picture)Slow conduction; prolong the refractory period; affect the normal heart; flecainide prolongs the PR, QRS and QT intervalsLife-threatening ventricular tachycardia or fibrillation; refractory supraventricular tachycardia; flecainide prevents premature ventricular contractionsIncreased mortality after myocardial infarction (flecainide); proarrhythmia (ventricular tachycardia resistant to treatment); bronchospasm; blurred vision; thrombocytopenia; propafenone: agranulocytosis, worsened heart failureFlecainide only without significant structural heart damage; long half-life (14 hours)L10
slide 20
slide 21
slide 22
slide 23
slide 24
Class II
propranolol (nonselective); metoprolol, acebutolol, esmolol (beta-1 selective)
Beta receptorsFlatter phase 4 in pacemaker cells, so the next beat comes later (slide 25 picture)Slow conduction; decrease automaticity; prolong atrioventricular conduction; negative inotropic and chronotropic effects; propranolol is membrane stabilizingSupraventricular arrhythmias; ventricular ectopic beats and myocardial infarction (propranolol); esmolol is the intravenous short-acting agentHeart failure, heart block, hypotension, bronchospasm (less with beta-1 selective agents); sedation and fatigueAsthma (use a beta-1 selective agent); digitalis toxicity with digoxinL10
slide 25
slide 26
slide 28
slide 29
Class III
amiodarone, dofetilide, sotalol
Potassium channels (reduce potassium efflux); amiodarone also blocks inactivated sodium channels, calcium channels and alpha and beta receptors; sotalol is also a beta blockerLonger action potential: phase 3 repolarization delayed; upstroke unchanged (slide 30 picture)Prolong phase 3 repolarization, the refractory period and the action potential durationAmiodarone: recurrent ventricular tachycardia or fibrillation resistant to other drugs, atrial fibrillation; intravenous for acute ventricular tachycardia or fibrillation. Dofetilide: normal rhythm in atrial fibrillation. Sotalol: atrial flutter and fibrillation, ventricular tachyarrhythmiaAmiodarone: pulmonary fibrosis, thyroid (hyper or hypo), blue-gray skin, corneal deposits, hepatic dysfunction. Dofetilide and sotalol: torsades de pointes; dofetilide marked QT prolongation; sotalol bronchospasmAmiodarone: half-life about 40 days, loading doses; raises digoxin, warfarin, flecainide, phenytoin, procainamide. Dofetilide: special training; renal eliminationL10
slide 30
slide 31
slide 32
slide 33
slide 34
slide 35
Class IV
verapamil, diltiazem
L-type calcium channel (both activated and inactivated channels; most effective in the most active tissue)Flatter phase 4 in pacemaker cells, as with class II (slide 37 picture)Decrease automaticity; slow atrioventricular node conduction; suppress the sinoatrial node; negative inotropicParoxysmal supraventricular tachycardia; atrial fibrillationHypotension, edemaAvoid in ventricular arrhythmias, sick sinus syndrome, depressed cardiac function; caution in liver damageL10
slide 37
slide 38
slide 39
Adenosine
miscellaneous
Activates potassium channels in the atria and blocks calcium channelsHyperpolarizes cellsDecreases conduction velocity (may stop the heart for 2 to 3 seconds); decreases automaticity; prolongs the refractory period; half-life about 10 secondsParoxysmal supraventricular tachycardia (Wolff-Parkinson-White is also listed)Flushing (20 percent), shortness of breath, burning in the chest—L10
slide 41
slide 42
Digoxin
digitalis; miscellaneous
Sodium-potassium ATPase inhibition; also listed: inhibits calcium channels in the atrioventricular node—Slows atrioventricular conduction; indirectly increases parasympathetic tone and decreases sympathetic tone; can induce heart blockSlow the ventricular rate; induce heart block in atrial flutter and fibrillationNausea, vomiting, diarrhea, anorexia; confusion, delirium, headache, seizures, visual disturbancesAvoid calcium channel blockers and beta blockers with itL10
slide 43
slide 44
Magnesium sulfate
miscellaneous
———Torsades de pointes (intravenous)Bradycardia, flushing, headache, respiratory paralysis—L10
slide 45